Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.31 |
| ▸ | PKM | P14618 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PREP | P48147 | 1/20 | 0.31 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31163697 | 1.00 | ACHE (0.32) | ACHEHTTGAAKDM4ETP53 | |
| SCHEMBL4194167 | 0.93 | KDM4E (0.32) | ACHEHTTGAAKDM4ETP53 | |
| SCHEMBL8910403 | 0.92 | TERT (0.36) | KDM4EPKMLMNAALDH1A1 | |
| SCHEMBL29373064 | 0.92 | TERT (0.36) | KDM4EPKMLMNAALDH1A1 | |
| Trifluoromethanesulfonic Acid SCHEMBL21542360 | 0.91 | ACHE (0.31) | ACHE | |
| SCHEMBL13633675 | 0.88 | ACHE (0.33) | ACHETP53MAPTKMT2A | |
| SCHEMBL7531675 | 0.88 | — | — | |
| SCHEMBL4187500 | 0.88 | POLB (0.31) | ACHETP53MAPTKMT2A | |
| SCHEMBL17898188 | 0.86 | KDM4E (0.36) | GAAKDM4EMAPTHSD17B10LMNA | |
| SCHEMBL4535032 | 0.85 | KMT2A (0.39) | KDM4EMAPTHSD17B10KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11932603-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-03-19 | — | — | US | disclosed |
| US-20220227711-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-07-21 | — | — | US | disclosed |
| US-11332445-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-05-17 | — | — | US | disclosed |
| US-20200190037-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2020-06-18 | — | — | US | disclosed |
| EP-3019575-B1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2018-12-19 | — | — | EP | disclosed |
| EP-3067345-B1 | ZWITTERION-CONTAINING ACRIDINIUM COMPOUNDS | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2018-09-05 | — | — | EP | disclosed |
| US-20170320830-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2017-11-09 | — | — | US | disclosed |
| US-20170320830-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2017-11-09 | — | — | US | disclosed |
| US-20170320830-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2017-11-09 | — | — | US | disclosed |
| US-9575062-B2 | Zwitterion-containing acridinium compounds | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2017-02-21 | — | — | US | disclosed |
| US-20100099077-A1 | STABLE ACRIDINIUM ESTERS WITH FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2010-04-22 | — | — | US | disclosed |
| US-20090318627-A1 | SOLID PHASE SYNTHESIS OF ACRIDINIUM DERIVATIVES | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2009-12-24 | — | — | US | disclosed |
| US-20090318627-A1 | SOLID PHASE SYNTHESIS OF ACRIDINIUM DERIVATIVES | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2009-12-24 | — | — | US | disclosed |
| US-20080014660-A1 | High Quantum Yield Acridinium Compounds and Their Uses in Improving Assay Sensitivity | BAYER HEALTHCARE LLC | 2008-01-17 | — | — | US | disclosed |
| US-20080014660-A1 | High Quantum Yield Acridinium Compounds and Their Uses in Improving Assay Sensitivity | BAYER HEALTHCARE LLC | 2008-01-17 | — | — | US | disclosed |
| US-20080014660-A1 | High Quantum Yield Acridinium Compounds and Their Uses in Improving Assay Sensitivity | BAYER HEALTHCARE LLC | 2008-01-17 | — | — | US | disclosed |
| US-7309615-B2 | High quantum yield acridinium compounds and their uses in improving assay sensitivity | SIEMENS MEDICAL SOLUTIONS DIAGNOSTIC (US) | 2007-12-18 | — | — | US | disclosed |
| US-7309615-B2 | High quantum yield acridinium compounds and their uses in improving assay sensitivity | SIEMENS MEDICAL SOLUTIONS DIAGNOSTIC (US) | 2007-12-18 | — | — | US | disclosed |
| WO-2007092847-A2 | SOLID PHASE SYNTHESIS OF ACRIDINIUM DERIVATIVES | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2007-08-16 | — | — | WO | disclosed |
| US-20050221390-A1 | High quantum yield acridinium compounds and their uses in improving assay sensitivity | BAYER HEALTHCARE LLC (US) | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190037-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | ACR, HACD3, FCGR3B | ACHE 860/4885HTT 412/4885GAA 710/4885 |
| US-20170320830-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | ACR, HACD3, FCGR3B | ACHE 860/4885HTT 412/4885GAA 710/4885 |
| US-11332445-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | ACR, HACD3, FCGR3B | ACHE 860/4885HTT 412/4885GAA 710/4885 |
| US-20220227711-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | ACR, HACD3, FCGR3B | ACHE 860/4885HTT 412/4885GAA 710/4885 |
| US-20100099077-A1 | STABLE ACRIDINIUM ESTERS WITH FAST LIGHT EMISSION | ACR, NAALAD2, CES2 | ACHE 693/4885HTT 1427/4885GAA 69/4885 |
| US-20090318627-A1 | SOLID PHASE SYNTHESIS OF ACRIDINIUM DERIVATIVES | ACR, SSU72, SP1 | ACHE 2066/4885HTT 2887/4885GAA 3503/4885 |
| US-11932603-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | ACR, HACD3, FCGR3B | ACHE 860/4885HTT 412/4885GAA 710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.